Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tenofovir in pregnant women with HBV
NCT04114890Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by University of Oxford. Primary endpoints: Area under the plasma concentration-time curve and Maximum plasma drug concentration. Started Jan 2021; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04114890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04114890.